ArticleRevista peruana de medicina experimental y salud publica

Characterization of adverse events to hydroxychloroquine, ivermectin, azithromycin and tocilizumab in patients hospitalized due to COVID-19 in a Peruvian Social Health Insurance hospital.

L Yesenia Rodríguez-Tanta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.